FDA Approved Drugs for Internal Medicine

Drugs Approved in 2018

Tegsedi (inotersen); Ionis Pharmaceuticals; For the treatment of the polyneuropathy of hereditary transthyretinmediated amyloidosis in adults, Approved October 2018

Drugs Approved in 2017

Duzallo (lesinurad and allopurinol) ; Ardea Biosciences; For the treatment of hyperuricemia associated with gout , Approved August 2017

Drugs Approved in 2014

Cerdelga (eliglustat); Genzyme; For the treatment of certain adult patients with Gaucher disease type 1, Approved August 2014